Skip to main content
SpringerLink
Log in

Extended Lymphadenectomy in Esophageal Cancer is Crucial

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Surgery with lymphadenectomy remains the mainstay of treatment for esophageal cancer. The optimal extent of nodal dissection is controversial. Evidence is accumulating, however, that could demonstrate the benefits of extended lymphadenectomy, which include more accurate disease staging, better locoregional disease control, and improved survival. Except in very early disease where nodal metastases are rare, extended lymphadenectomy is indicated. Data from a randomized controlled trial comparing transhiatal and transthoracic resection have shown better survival in patients with limited nodal burden. Other investigations on en bloc resection, three-field lymphadenectomy, and large-scale international collaborative studies have all provided evidence for the more extensive approach to enhance cure for esophageal cancer. The more extended surgery does lead to potentially higher morbidity rates, and thus surgeons should be versatile in applying such techniques in carefully selected patients, so that postoperative survival and quality of life of patients are not compromised. The challenge in the future is how to tailor surgical strategies for individual patients in order to achieve the best outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123:432–439

    Article  PubMed  CAS  Google Scholar 

  2. Stein HJ, Feith M, Bruecher BL et al. (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242:566–573; discussion 573–575

    Google Scholar 

  3. American Joint Committee on Cancer (2009) Esophagus. AJCC cancer staging manual. Springer, New York

    Google Scholar 

  4. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669

    Article  PubMed  Google Scholar 

  5. Akiyama H, Tsurumaru M, Udagawa H et al. (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220:364–372; discussion 372–373

    Google Scholar 

  6. Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236:177–183

    Article  PubMed  Google Scholar 

  7. Siewert JR, Fink U, Beckurts KT et al. (1994) Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 5(Suppl)3:1–7

    Google Scholar 

  8. Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371

    Article  PubMed  Google Scholar 

  9. Roder JD, Busch R, Stein HJ et al (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81:410–413

    Article  PubMed  CAS  Google Scholar 

  10. Hagen JA, DeMeester SR, Peters JH et al. (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530; discussion 530–531

    Google Scholar 

  11. Wijnhoven BP, Tran KT, Esterman A et al (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245:717–725

    Article  PubMed  Google Scholar 

  12. Lagarde SM, Reitsma JB, de Castro SM et al (2007) Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg 94:1361–1368

    Article  PubMed  CAS  Google Scholar 

  13. Lagarde SM, Cense HA, Hulscher JB et al (2005) Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest. Br J Surg 92:1404–1408

    Article  PubMed  CAS  Google Scholar 

  14. Lerut T, Nafteux P, Moons J et al. (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962–972; discussion 972–974

    Google Scholar 

  15. Boshier PR, Anderson O, Hanna GB (2011) Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis. Ann Surg 254:894–906

    Article  PubMed  Google Scholar 

  16. Chang AC, Ji H, Birkmeyer NJ et al (2008) Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85:424–429

    Article  PubMed  Google Scholar 

  17. Chu KM, Law SY, Fok M et al (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 174:320–324

    Article  PubMed  CAS  Google Scholar 

  18. Jacobi CA, Zieren HU, Muller JM et al (1996) Systematic lymphadenectomy in esophageal carcinoma—preliminary results of a prospective randomized study. Zentralbl Chir 121:110–115

    PubMed  CAS  Google Scholar 

  19. Goldminc M, Maddern G, Le Prise E et al (1993) Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 80:367–370

    Article  PubMed  CAS  Google Scholar 

  20. Omloo JM, Lagarde SM, Hulscher JB et al. (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992–1000; discussion 1001

    Google Scholar 

  21. Logan A (1963) The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg 46:150–161

    PubMed  CAS  Google Scholar 

  22. Skinner DB, Little AG, Ferguson MK et al (1986) Selection of operation for esophageal cancer based on staging. Ann Surg 204:391–401

    Article  PubMed  CAS  Google Scholar 

  23. Tachibana M, Kinugasa S, Yoshimura H et al (2004) En-bloc esophagectomy for esophageal cancer. Am J Surg 188:254–260

    Article  PubMed  Google Scholar 

  24. Barbier PA, Luder PJ, Schupfer G et al (1988) Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: results of a prospective follow-up in 50 patients. World J Surg 12:270–276. doi:10.1007/BF01658073

    Article  PubMed  CAS  Google Scholar 

  25. Clark GW, Peters JH, Ireland AP et al. (1994) Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 58:646–653; discussion 653–654

    Google Scholar 

  26. Hagen JA, Peters JH, DeMeester TR (1993) Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 106:850–858; discussion 858–859

    Google Scholar 

  27. Johansson J, DeMeester TR, Hagen JA et al. (2004) En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139:627–631; discussion 631–633

    Google Scholar 

  28. Portale G, Hagen JA, Peters JH et al. (2006) Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202:588–596; discussion 596–598

    Google Scholar 

  29. Akiyama H, Tsurumaru M, Kawamura T et al (1981) Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg 194:438–446

    Article  PubMed  CAS  Google Scholar 

  30. Ilson DH, Kelsen DP (1994) Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 21:493–507

    PubMed  CAS  Google Scholar 

  31. Kelsen DP, Ilson DH (1995) Chemotherapy and combined-modality therapy for esophageal cancer. Chest 107:224S–232S

    Article  PubMed  CAS  Google Scholar 

  32. Tachibana M, Kinugasa S, Yoshimura H (2003) Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 138:1383–1389 discussion 1390

    Article  PubMed  Google Scholar 

  33. Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222:654–662

    Article  PubMed  CAS  Google Scholar 

  34. Baba M, Aikou T, Yoshinaka H et al (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219:310–316

    Article  PubMed  CAS  Google Scholar 

  35. Nishimaki T, Suzuki T, Suzuki S et al (1998) Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186:306–312

    Article  PubMed  CAS  Google Scholar 

  36. Udagawa H, Ueno M, Shinohara H et al (2012) The importance of grouping of lymph node stations and rationale of three-field lymphadenectomy for thoracic esophageal cancer. J Surg Oncol 106:742–747

    Article  PubMed  Google Scholar 

  37. Shiozaki H, Yano M, Tsujinaka T et al (2001) Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus 14:191–196

    Article  PubMed  CAS  Google Scholar 

  38. Kato H, Watanabe H, Tachimori Y et al (1991) Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 51:931–935

    Article  PubMed  CAS  Google Scholar 

  39. Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51

    Article  PubMed  CAS  Google Scholar 

  40. Peyre CG, Hagen JA, DeMeester SR et al (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–556

    Article  PubMed  Google Scholar 

  41. Rizk NP, Ishwaran H, Rice TW et al (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251:46–50

    Article  PubMed  Google Scholar 

  42. Groth SS, Virnig BA, Whitson BA et al (2010) Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg 139:612–620

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Esophageal and Upper Gastrointestinal Surgery, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, Hong Kong

    Daniel Tong & Simon Law

Authors
  1. Daniel Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon Law
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Law.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tong, D., Law, S. Extended Lymphadenectomy in Esophageal Cancer is Crucial. World J Surg 37, 1751–1756 (2013). https://doi.org/10.1007/s00268-013-2068-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-013-2068-8

Keywords

Search

Navigation